SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Abbott Laboratories's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy